sr 95531 has been researched along with thiomuscimol in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (thiomuscimol) | Trials (thiomuscimol) | Recent Studies (post-2010) (thiomuscimol) |
---|---|---|---|---|---|
610 | 0 | 209 | 6 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chambon, JP; Melikian, A; Schlewer, G; Wermuth, CG | 1 |
1 other study(ies) available for sr 95531 and thiomuscimol
Article | Year |
---|---|
Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists.
Topics: Animals; Binding, Competitive; Convulsants; Female; GABA-A Receptor Antagonists; In Vitro Techniques; Mice; Models, Molecular; Molecular Conformation; Muscimol; Pyridazines; Radioligand Assay; Rats; Receptors, GABA-A; Structure-Activity Relationship | 1992 |